Although much remains to be learned about the immune-mediated myositis synd
romes, information generated from recent studies in a number of areas may a
ssist physicians in patient management. Topics reviewed here include: data
supporting the association of myositis with cancer and the appropriate eval
uations for malignancy in a myositis patient; an approach to the assessment
of patients with dermatomyositis sine myositis; the usefulness of the clin
icopathological and serological classifications; a discussion of whether ch
ildhood and adult myositis are the same or different entities; a review of
those prognostic factors to consider in the clinical management of myositis
patients; current approaches and their limitations for assessing disease a
ctivity and damage. To improve our limited understanding of the myositis sy
ndromes, national and international collaborations are needed to obtain the
necessary numbers of subjects, given the rarity and heterogeneity of these
disorders.